Get all your news in one place.
100's of premium titles.
One app.
Start reading
Evening Standard
Evening Standard
Science
Anna Wise

GSK acquiring firm developing food allergy treatment in £1.6bn deal

GSK has agreed to buy a pharmaceutical firm that is developing treatment for people with food allergies (GSK/PA) -

GSK has agreed to buy a pharmaceutical firm that is developing treatment for people with food allergies in a deal valued at 2.2 billion US dollars (£1.6 billion).

The London-listed company said the acquisition of Rapt Therapeutics includes ozureprubart, an antibody currently in phase two clinical development for prophylactic protection against food allergens.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.